Australia markets closed

ETON Aug 2024 2.500 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
1.30000.0000 (0.00%)
As of 10:25AM EDT. Market open.
Full screen
Previous close1.3000
Open1.3000
Bid0.0000
Ask0.0000
Strike2.50
Expiry date2024-08-16
Day's range1.3000 - 1.3000
Contract rangeN/A
Volume1
Open interest10
  • Simply Wall St.

    Eton Pharmaceuticals First Quarter 2024 Earnings: EPS Beats Expectations

    Eton Pharmaceuticals ( NASDAQ:ETON ) First Quarter 2024 Results Key Financial Results Revenue: US$7.97m (up 50% from 1Q...

  • Thomson Reuters StreetEvents

    Q1 2024 Eton Pharmaceuticals Inc Earnings Call

    Q1 2024 Eton Pharmaceuticals Inc Earnings Call

  • GlobeNewswire

    Eton Pharmaceuticals Reports First Quarter 2024 Financial Results

    • Q1 2024 revenue of $8.0 million, representing 50% growth over Q1 2023 and the 13th straight quarter of sequential product sales growth• Acquired PKU GOLIKE®, launched Nitisinone, and submitted a new drug application (NDA) for product candidate ET-400• Management to hold conference call today at 4:30pm ET DEER PARK, Ill., May 09, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commerciali